10 20 30 40 50 60 70 80 2FGI - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric Unit
HEADER TRANSFERASE 15-SEP-98 2FGI
TITLE CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FGF TITLE 2 RECEPTOR 1 IN COMPLEX WITH INHIBITOR PD173074
COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (FIBROBLAST GROWTH FACTOR (FGF) RECEPTOR COMPND 3 1); COMPND 4 CHAIN: A, B; COMPND 5 FRAGMENT: TYROSINE KINASE DOMAIN; COMPND 6 SYNONYM: FGFR1K; COMPND 7 EC: 2.7.1.112; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL_LINE: SF9; SOURCE 6 CELLULAR_LOCATION: CYTOPLASM; SOURCE 7 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 8 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 10 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 11 EXPRESSION_SYSTEM_VECTOR: BACULOVIRUS
KEYWDS PROTEIN KINASE, TYROSINE-PROTEIN KINASE, ATP-BINDING, KEYWDS 2 PHOSPHORYLATION, INHIBITOR, TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR M.MOHAMMADI,S.FROUM,J.M.HAMBY,M.SCHROEDER,R.L.PANEK,G.H.LU, AUTHOR 2 A.V.ELISEENKOVA,D.GREEN,J.SCHLESSINGER,S.R.HUBBARD
REVDAT 2 24-FEB-09 2FGI 1 VERSN REVDAT 1 13-SEP-99 2FGI 0
JRNL AUTH M.MOHAMMADI,S.FROUM,J.M.HAMBY,M.C.SCHROEDER, JRNL AUTH 2 R.L.PANEK,G.H.LU,A.V.ELISEENKOVA,D.GREEN, JRNL AUTH 3 J.SCHLESSINGER,S.R.HUBBARD JRNL TITL CRYSTAL STRUCTURE OF AN ANGIOGENESIS INHIBITOR JRNL TITL 2 BOUND TO THE FGF RECEPTOR TYROSINE KINASE DOMAIN. JRNL REF EMBO J. V. 17 5896 1998 JRNL REFN ISSN 0261-4189 JRNL PMID 9774334 JRNL DOI 10.1093/EMBOJ/17.20.5896
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.816 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 6.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 100000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.1000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 85.6 REMARK 3 NUMBER OF REFLECTIONS : 23530 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.300 REMARK 3 FREE R VALUE TEST SET COUNT : 1185 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4306 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 76 REMARK 3 SOLVENT ATOMS : 191 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 9.80000 REMARK 3 B22 (A**2) : -20.01000 REMARK 3 B33 (A**2) : 10.21000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 4.14000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.36 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.08 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.570 ; 1.000 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.680 ; 1.500 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.740 ; 1.500 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.250 ; 2.000 REMARK 3 REMARK 3 NCS MODEL : UNRESTRAINED REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARAMCSDX.PRO REMARK 3 PARAMETER FILE 2 : PARAM19.SOL REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 2 : TOPH19.SOL REMARK 3 TOPOLOGY FILE 3 : TOPHCSDX.MISC REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 2FGI COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-JUL-99. REMARK 100 THE RCSB ID CODE IS RCSB007108.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-AUG-97 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : YALE MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IIC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24664 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.5 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.04700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.68 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16% PEG 10000, 0.3 M (NH4)2SO4, 100 REMARK 280 MM BIS-TRIS, PH 6.5, 5% ETHYLENE GLYCOL
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 104.39500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.69000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 104.39500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 28.69000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 456 REMARK 465 VAL A 457 REMARK 465 ALA A 458 REMARK 465 GLY A 459 REMARK 465 VAL A 460 REMARK 465 SER A 461 REMARK 465 GLU A 462 REMARK 465 TYR A 463 REMARK 465 GLU A 486 REMARK 465 GLY A 487 REMARK 465 ALA A 488 REMARK 465 PHE A 489 REMARK 465 GLY A 490 REMARK 465 ASP A 501 REMARK 465 LYS A 502 REMARK 465 ASP A 503 REMARK 465 LYS A 504 REMARK 465 GLY A 580 REMARK 465 LEU A 581 REMARK 465 GLU A 582 REMARK 465 TYR A 583 REMARK 465 SER A 584 REMARK 465 TYR A 585 REMARK 465 ASN A 586 REMARK 465 PRO A 587 REMARK 465 SER A 588 REMARK 465 HIS A 589 REMARK 465 ASN A 590 REMARK 465 PRO A 591 REMARK 465 GLU A 592 REMARK 465 GLU A 593 REMARK 465 ARG A 646 REMARK 465 THR A 658 REMARK 465 ASN A 763 REMARK 465 GLN A 764 REMARK 465 GLU A 765 REMARK 465 MET B 456 REMARK 465 VAL B 457 REMARK 465 ALA B 458 REMARK 465 GLY B 459 REMARK 465 VAL B 460 REMARK 465 ASP B 501 REMARK 465 LYS B 502 REMARK 465 ASP B 503 REMARK 465 LYS B 504 REMARK 465 PRO B 578 REMARK 465 PRO B 579 REMARK 465 GLY B 580 REMARK 465 LEU B 581 REMARK 465 GLU B 582 REMARK 465 TYR B 583 REMARK 465 SER B 584 REMARK 465 TYR B 585 REMARK 465 ASN B 586 REMARK 465 PRO B 587 REMARK 465 SER B 588 REMARK 465 HIS B 589 REMARK 465 ASN B 590 REMARK 465 PRO B 591 REMARK 465 GLU B 592 REMARK 465 GLU B 593 REMARK 465 ARG B 646 REMARK 465 ASP B 647 REMARK 465 ILE B 648 REMARK 465 HIS B 649 REMARK 465 HIS B 650 REMARK 465 ILE B 651 REMARK 465 THR B 657 REMARK 465 THR B 658 REMARK 465 ASN B 659 REMARK 465 SER B 762 REMARK 465 ASN B 763 REMARK 465 GLN B 764 REMARK 465 GLU B 765
REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 464 CG CD OE1 OE2 REMARK 470 GLN A 491 CG CD OE1 NE2 REMARK 470 SER A 518 OG REMARK 470 ASP A 519 CG OD1 OD2 REMARK 470 GLU A 522 CG CD OE1 OE2 REMARK 470 GLU A 707 CG CD OE1 OE2 REMARK 470 GLU B 462 CG CD OE1 OE2 REMARK 470 LYS B 482 CG CD CE NZ REMARK 470 GLU B 486 CG CD OE1 OE2 REMARK 470 ASN B 506 CG OD1 ND2 REMARK 470 ARG B 507 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 542 CG CD CE NZ REMARK 470 GLN B 594 CG CD OE1 NE2 REMARK 470 GLU B 707 CG CD OE1 OE2
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 519 32.99 -91.81 REMARK 500 ASN A 543 33.75 -97.78 REMARK 500 ASP A 554 75.56 40.88 REMARK 500 ALA A 575 10.78 -66.39 REMARK 500 ARG A 622 -27.10 83.95 REMARK 500 ASN A 724 75.82 55.98 REMARK 500 CYS A 725 133.04 -177.49 REMARK 500 ASN B 506 32.60 -144.89 REMARK 500 ARG B 622 -0.26 70.47 REMARK 500 ASP B 623 36.14 -155.29 REMARK 500 ARG B 675 15.41 55.29 REMARK 500 ASN B 724 77.06 70.62 REMARK 500 CYS B 725 112.22 174.31 REMARK 500 LEU B 760 45.56 -97.46 REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PD1 B 1000 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PD1 A 1001
DBREF 2FGI A 456 765 UNP P11362 FGFR1_HUMAN 456 765 DBREF 2FGI B 456 765 UNP P11362 FGFR1_HUMAN 456 765
SEQADV 2FGI VAL A 457 UNP P11362 LEU 457 ENGINEERED SEQADV 2FGI ALA A 488 UNP P11362 CYS 488 ENGINEERED SEQADV 2FGI SER A 584 UNP P11362 CYS 584 ENGINEERED SEQADV 2FGI VAL B 457 UNP P11362 LEU 457 ENGINEERED SEQADV 2FGI ALA B 488 UNP P11362 CYS 488 ENGINEERED SEQADV 2FGI SER B 584 UNP P11362 CYS 584 ENGINEERED
SEQRES 1 A 310 MET VAL ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP SEQRES 2 A 310 PRO ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY SEQRES 3 A 310 LYS PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL LEU SEQRES 4 A 310 ALA GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG SEQRES 5 A 310 VAL THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA SEQRES 6 A 310 THR GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU SEQRES 7 A 310 MET MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN SEQRES 8 A 310 LEU LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL SEQRES 9 A 310 ILE VAL GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR SEQRES 10 A 310 LEU GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR SEQRES 11 A 310 ASN PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS SEQRES 12 A 310 ASP LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET SEQRES 13 A 310 GLU TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU SEQRES 14 A 310 ALA ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET SEQRES 15 A 310 LYS ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS SEQRES 16 A 310 ILE ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO SEQRES 17 A 310 VAL LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE SEQRES 18 A 310 TYR THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU SEQRES 19 A 310 LEU TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO SEQRES 20 A 310 GLY VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU SEQRES 21 A 310 GLY HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU SEQRES 22 A 310 LEU TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SEQRES 23 A 310 SER GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU SEQRES 24 A 310 ASP ARG ILE VAL ALA LEU THR SER ASN GLN GLU SEQRES 1 B 310 MET VAL ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP SEQRES 2 B 310 PRO ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY SEQRES 3 B 310 LYS PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL LEU SEQRES 4 B 310 ALA GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG SEQRES 5 B 310 VAL THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA SEQRES 6 B 310 THR GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU SEQRES 7 B 310 MET MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN SEQRES 8 B 310 LEU LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL SEQRES 9 B 310 ILE VAL GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR SEQRES 10 B 310 LEU GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR SEQRES 11 B 310 ASN PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS SEQRES 12 B 310 ASP LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET SEQRES 13 B 310 GLU TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU SEQRES 14 B 310 ALA ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET SEQRES 15 B 310 LYS ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS SEQRES 16 B 310 ILE ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO SEQRES 17 B 310 VAL LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE SEQRES 18 B 310 TYR THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU SEQRES 19 B 310 LEU TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO SEQRES 20 B 310 GLY VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU SEQRES 21 B 310 GLY HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU SEQRES 22 B 310 LEU TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SEQRES 23 B 310 SER GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU SEQRES 24 B 310 ASP ARG ILE VAL ALA LEU THR SER ASN GLN GLU
HET PD1 B1000 38 HET PD1 A1001 38
HETNAM PD1 1-TERT-BUTYL-3-[6-(3,5-DIMETHOXY-PHENYL)-2-(4- HETNAM 2 PD1 DIETHYLAMINO-BUTYLAMINO)-PYRIDO[2,3-D]PYRIMIDIN-7-YL]- HETNAM 3 PD1 UREA
HETSYN PD1 PD 173074
FORMUL 3 PD1 2(C28 H41 N7 O3) FORMUL 5 HOH *191(H2 O)
HELIX 1 AC GLU A 522 ILE A 538 1SEE REMARK 650 17 HELIX 2 AD LEU A 569 GLN A 574 1 6 HELIX 3 AE SER A 597 SER A 616 1 20 HELIX 4 AEF PRO A 669 ASP A 674 1 6 HELIX 5 AF HIS A 679 PHE A 694 1 16 HELIX 6 AG VAL A 706 LYS A 714 1 9 HELIX 7 AH ASN A 727 CYS A 736 1 10 HELIX 8 AI PHE A 747 LEU A 760 1 14 HELIX 9 BC GLU B 522 ILE B 538 1 17 HELIX 10 BD LEU B 569 GLN B 574 1 6 HELIX 11 BE SER B 597 SER B 616 1 20 HELIX 12 BEF PRO B 669 ASP B 674 1 6 HELIX 13 BF HIS B 679 PHE B 694 1 16 HELIX 14 BG VAL B 706 LYS B 714 1 9 HELIX 15 BH ASN B 727 CYS B 736 1 10 HELIX 16 BI PHE B 747 LEU B 760 1 14
SHEET 1 A 5 LEU A 547 CYS A 551 0 SHEET 2 A 5 TYR A 558 VAL A 561 -1 N ILE A 560 O LEU A 548 SHEET 3 A 5 VAL A 508 LYS A 514 -1 N LYS A 514 O VAL A 559 SHEET 4 A 5 VAL A 492 ILE A 498 -1 N ALA A 497 O THR A 509 SHEET 5 A 5 LEU A 478 PRO A 483 -1 N LYS A 482 O LEU A 494 SHEET 1 B 2 VAL A 629 VAL A 631 0 SHEET 2 B 2 MET A 637 ILE A 639 -1 N LYS A 638 O LEU A 630 SHEET 1 C 5 LEU B 547 CYS B 551 0 SHEET 2 C 5 TYR B 558 GLU B 562 -1 N ILE B 560 O LEU B 548 SHEET 3 C 5 VAL B 508 LEU B 516 -1 N LYS B 514 O VAL B 559 SHEET 4 C 5 GLY B 490 ILE B 498 -1 N ALA B 497 O THR B 509 SHEET 5 C 5 LEU B 478 GLU B 486 -1 N LYS B 482 O LEU B 494 SHEET 1 D 2 VAL B 629 VAL B 631 0 SHEET 2 D 2 MET B 637 ILE B 639 -1 N LYS B 638 O LEU B 630
SITE 1 AC1 16 LEU B 484 GLY B 485 GLU B 486 VAL B 492 SITE 2 AC1 16 LYS B 514 GLU B 531 ILE B 545 VAL B 559 SITE 3 AC1 16 VAL B 561 GLU B 562 TYR B 563 ALA B 564 SITE 4 AC1 16 SER B 565 GLU B 571 LEU B 630 ASP B 641 SITE 1 AC2 18 HOH A 30 LEU A 484 GLY A 485 VAL A 492 SITE 2 AC2 18 LYS A 514 MET A 535 ILE A 545 VAL A 559 SITE 3 AC2 18 VAL A 561 GLU A 562 TYR A 563 ALA A 564 SITE 4 AC2 18 SER A 565 GLY A 567 LEU A 630 ALA A 640 SITE 5 AC2 18 ASP A 641 PHE A 642
CRYST1 208.790 57.380 66.180 90.00 107.55 90.00 C 1 2 1 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.004790 0.000000 0.001515 0.00000
SCALE2 0.000000 0.017428 0.000000 0.00000
SCALE3 0.000000 0.000000 0.015848 0.00000
MTRIX1 1 -0.994400 -0.097730 0.040290 72.51800 1
MTRIX2 1 -0.103880 0.832770 -0.543790 12.24300 1
MTRIX3 1 0.019590 -0.544930 -0.838260 28.15900 1